In addition, AD fractions were enriched with proteins such as kallikrein-4 (KLK4), flotilin-2 (FLOT2), RTN3 and RTN4 (the latter is also known as Nogo; Fig. 1C), which were previously shown to alter neuronal APP processing [68–71]. The gene discussed is APP; the disease is Alzheimer disease.